Archive Category: 10X Stocks Archive

Hello, and welcome back to 10X Stocks! As I write, we’ve got not one but two different stocks charging past 700% gains on the way to becoming our first true 10X position. Of course, I’m speaking about nuclear power innovator Nuscale Power (SMR) and our play in the health care space, Hims & Hers Health (HIMS), which are currently up 786% and 722%, respectively.

The Nuclear Regulatory Commission (NRC) is not the kind of agency most Americans think about often. In fact, there’s a decent chance you’ve never even heard of it outside of a few advanced social studies classes in high school or college. The NRC was originally established back in 1975 as a successor to the United States Atomic Energy Commission. Then, just a few years later, in 1979, there was a partial meltdown in the Unit 2 reactor at the Three Mile Island Nuclear Generating Station.

Based on some limited polling, I know that many of you 10Xers out there are either entrepreneurs, high-level professionals, or have experience working at the executive level. So I’d like to start today’s update off with a hypothetical that takes advantage of some of that experience… Let’s pretend for just a moment that we’re all sitting at a corporate board meeting — all 12,238 paid-up 10Xers around the same gigantic conference table.

Markets will close at 1:00 p.m. ET this afternoon in anticipation of the upcoming Fourth of July holiday weekend, so I’ll keep this update brief… 2025 is shaping up to be a banner year for our 10X Stocks strategy… In the model portfolio, we have five positions with triple-digit open gains, with two (HIMS and SMR) around the halfway point to 10X gains.

Earlier this week, pharmaceutical giant Novo Nordisk (NVO) abruptly bailed on its landmark deal with Hims & Hers — even though it’s been less than two months since the deal was first announced. HIMS stock crashed almost 35% on Monday following news that Novo would no longer allow Hims & Hers to sell its popular GLP-1 weight-loss treatment, Wegovy.